PTP4A3 and acute lymphoblastic leukemia: In order to determine whether silencing PRL-3 expression in human T-ALL affects its oncogenic ability in vivo, Jurkat cells expressing a scrambled shRNA or a shRNA targeting PRL-3 were injected intravenously into immune-compromised mice.